Clinical Trials Logo

Multiple Trauma clinical trials

View clinical trials related to Multiple Trauma.

Filter by:

NCT ID: NCT04335838 Completed - Clinical trials for Traumatic Brain Injury

Age, Traumatic Brain Injury and Injury Severity as Independent Risk Factors for In-Hospital Mortality in Polytrauma Patients.

Start date: January 2012
Phase:
Study type: Observational

In this study patients who were admitted to our hospital with critical injuries were enrolled retrospectively from January 2012 to December 2015. Patients with an ISS>16 points, an AIS >3 in one body region and at least 2 different body regions affected were included. Possible prognostic factors were evaluated.

NCT ID: NCT04292262 Completed - Clinical trials for AKI (Acute Kidney Injury) Due to Trauma

Acute Kidney Injury in Polytrauma Patients in Intensive Care Unit

Start date: May 1, 2020
Phase:
Study type: Observational [Patient Registry]

Acute Kidney Injury (AKI) is a common complication of severe trauma patients and is associated with increased morbidity and mortality.Trauma patients have many risk factors for AKI such as hypovolemic shock, rhabdomyolysis, massive transfusion, major surgeries and abdominal compartment syndrome.The primary outcome of the study is to correlate between the AKI by using RIFLE criteria and the trauma severity by using ISS .The secondary outcomes are ;the length of ICU and hospital stay and 28 days mortality in AKI patients.

NCT ID: NCT04145271 Completed - Emergencies Clinical Trials

Pre-Hospital Zone 1 Partial Resuscitative Endovascular Balloon Occlusion of the Aorta for Injured Patients With Exsanguinating Sub-diaphragmatic Haemorrhage

P-PRO
Start date: June 27, 2020
Phase:
Study type: Observational

It is unknown whether this evolved strategy (Pre-Hospital Zone I P-REBOA) is feasible and with an acceptable safety profile. This study will address this question, therefore informing the design of a prospective multicentre exploratory cohort study followed by a pilot/feasibility multicenter RCT (IDEAL 2B). The IDEAL Framework is an internationally recognised standard, that describes the stages through which interventional therapy innovation normally passes, the characteristics of each stage and the study design types recommended for each

NCT ID: NCT04107818 Completed - Clinical trials for Coagulation Disorder

Comparison of Viscoelastic Measurement by ROTEM® Delta and ClotPro® in Trauma Patients.

ROTCLOT
Start date: November 21, 2019
Phase:
Study type: Observational

The purpose of the study is to describe the differences and interchangeability in measurements of viscoelastic tests of coagulation by two different devices in adult trauma patients.

NCT ID: NCT03999346 Completed - Trauma Clinical Trials

Opportunities and Limitations of Swiss Polytrauma Registry Data for Scientific Purposes- Registry Data for Scientific Purposes

Start date: November 1, 2018
Phase:
Study type: Observational

The aim of the analysis is an evaluation of the current performance of the Swiss Trauma Registry (STR) with respect to providing a reliable basis for (scientific) investigations on the management of trauma patients in Switzerland. The current project tries to address this question by considering central aspects of completeness and by exemplifying the use of the registry for research questions. The aim is to identify potential shortcomings of the registry.

NCT ID: NCT03952026 Completed - Polytrauma Clinical Trials

Impact of Associated Abdominal Injuries on Clinical and Operative Outcome in Pelvic Injuries

Start date: December 6, 2018
Phase:
Study type: Observational [Patient Registry]

Pelvic fractures are severe injuries which require advanced orthopedic surgical skills to treat. On the other hand, abdominal injuries are severe injuries, which might require quick general surgical treatment. The combination of both injuries is a challenge for orthopedic surgeons, as the abdominal injury might lead to a delayed surgical treatment of the pelvic fracture. Whether an associated abdominal injury influences the quality of care of pelvic fractures, is aim of this registry study.

NCT ID: NCT03906721 Completed - Clinical trials for Spinal Cord Injuries

Reduction of Opioid Dose Using Conditioning & Open-Label Placebo (COLP) in Patients With Spinal Cord Injury, Polytrauma and Burn Injury

Start date: February 20, 2019
Phase: Phase 2
Study type: Interventional

The use of conditioning open-label placebo (COLP) will be studied as a dose extension method to lower opioid dosage in patients with spinal cord injury, polytrauma, and burn injury. The goal is to provide the same level of pain relief with a reduced opioid dose to diminish adverse effects as well as the risk of addiction associated with narcotic treatment.

NCT ID: NCT03854591 Completed - Trauma, Multiple Clinical Trials

A Snapshot Study of Patients Affected by Gunshot Related Injuries in Trauma in South Africa

GRIT
Start date: February 18, 2019
Phase:
Study type: Observational

Introduction- Gun violence represents an important cause of disability to the working age population in South Africa. It has unrecognised, but undoubtedly significant implications for the health service and patients affected by these injuries. Aim- To capture the burden of gunshot injury across South Africa and to establish a network of researchers in this field. Method- A cross-sectional observational study run across South Africa capturing a nationwide picture of burden and complications associated with these injuries. Each centre will participate in a two-week window of patient screening and recruitment. Patients will be followed up at 6 weeks as per routine clinical practice. Data collected will include nature and number of treatments, length of stay, return to work and complications. Results-Outcome of the study will be disseminated to the participating centres, relevant health boards and published with all contributors across centres recognised.

NCT ID: NCT03819959 Completed - Critical Illness Clinical Trials

Metabolomics Study on Intensive Care Acquired Muscle Weakness in Polytrauma

MIRACLE II
Start date: March 24, 2019
Phase:
Study type: Observational

In this mono-center pilot trial, polytrauma patients admitted to intensive care will be included. Investigators are going to take blood and muscle samples at respecified time points to do metabolic, histological and molecular testing. Aim of the study is to investigate (1) changes of the blood metabolome in patients with ICUAW (intensive care unit acquired weakness) and (2) identify metabolic components who are responsible for ICUAW or can be used as marker for ICUAW.

NCT ID: NCT03780894 Completed - Polytrauma Clinical Trials

Transfusion of Red Blood Cells, Tranexamic Acid and Fibrinogen Concentrate for Severe Trauma Hemorrhage at Pre-hospital Phase of Care.

PRETIC
Start date: November 21, 2018
Phase: Phase 1/Phase 2
Study type: Interventional

This is a single-center, not-randomized, open-label, controlled pilot clinical trial. This study compares presence of Trauma Induced Coagulopathy (TIC) and acute traumatic hemorrhage treatment at pre-hospital phase of care with red blood cells (RBC), Tranexamic acid (TXA) and Fibrinogen Concentrate (FC) with the current treatment based on the administration of Crystalloids and TXA.